[artículo] 
inJournal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 429-434

Título :	Catechol-o-methyltransferase and monoamine oxidase a genotypes and drug response to conventional neuroleptics in schizophrenia
Tipo de documento:	texto impreso
Autores:	Ari Illi, Autor ; Kari M. Mattila, Autor ; Olli Kampman, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 429-434
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Monoaminooxidasa, Esquizofrenia - farmacoterapia.
Resumen:	Biogenic amine synthesis and degradation are involved in the pathogenesis of schizophrenia. Catechol-O-methyltransferase and monoamine oxidase enzymes are important agents in the metabolic inactivation of these neurotransmitters (ie, dopamine, serotonin, and norepinephrine). Functional polymorphism in the catechol-O-methyltransferase and monoamine oxidase A genes causes variation in enzyme activities.
Link:	./index.php?lvl=notice_display&id=30994

[artículo] Catechol-o-methyltransferase and monoamine oxidase a genotypes and drug response to conventional neuroleptics in schizophrenia [texto impreso] / Ari Illi, Autor ; Kari M. Mattila, Autor ; Olli Kampman, Autor . - 2023 . - pp. 429-434.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2003 - Vol. 23 - No. 5 (Octubre) . - pp. 429-434

Palabras clave:	Antipsicóticos, Monoaminooxidasa, Esquizofrenia - farmacoterapia.
Resumen:	Biogenic amine synthesis and degradation are involved in the pathogenesis of schizophrenia. Catechol-O-methyltransferase and monoamine oxidase enzymes are important agents in the metabolic inactivation of these neurotransmitters (ie, dopamine, serotonin, and norepinephrine). Functional polymorphism in the catechol-O-methyltransferase and monoamine oxidase A genes causes variation in enzyme activities.
Link:	./index.php?lvl=notice_display&id=30994